These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11857539)

  • 1. Screening of blood from potential organ and cornea donors for viruses.
    Miédougé M; Chatelut M; Mansuy JM; Rostaing L; Malecaze F; Sandres-Sauné K; Boudet F; Puel J; Abbal M; Izopet J
    J Med Virol; 2002 Apr; 66(4):571-5. PubMed ID: 11857539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
    Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and quantification of human immunodeficiency virus and hepatitis C virus in cadaveric tissue donors using different molecular tests.
    Ribeiro VST; Raboni SM; Suss PH; Cieslinski J; Kraft L; Dos Santos JS; Pereira L; Tuon FF
    J Clin Virol; 2019 Dec; 121():104203. PubMed ID: 31715525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective time-course study on serological testing for human immunodeficiency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death.
    Edler C; Wulff B; Schröder AS; Wilkemeyer I; Polywka S; Meyer T; Kalus U; Pruss A
    J Med Microbiol; 2011 Jul; 60(Pt 7):920-926. PubMed ID: 21436373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.
    Meng Q; Wong C; Rangachari A; Tamatsukuri S; Sasaki M; Fiss E; Cheng L; Ramankutty T; Clarke D; Yawata H; Sakakura Y; Hirose T; Impraim C
    J Clin Microbiol; 2001 Aug; 39(8):2937-45. PubMed ID: 11474017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV and hepatitis C virus RNA in seronegative organ and tissue donors.
    Challine D; Pellegrin B; Bouvier-Alias M; Rigot P; Laperche L; Pawlotsky JM
    Lancet; 2004 Oct 30-Nov 5; 364(9445):1611-2. PubMed ID: 15519632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
    Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
    Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation.
    Heim A; Wagner D; Rothämel T; Hartmann U; Flik J; Verhagen W
    J Med Virol; 1999 Jul; 58(3):291-5. PubMed ID: 10447426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological viral testing of cadaveric cornea donors.
    Challine D; Roudot-Thoraval F; Sabatier P; Dubernet F; Larderie P; Rigot P; Pawlotsky JM
    Transplantation; 2006 Sep; 82(6):788-93. PubMed ID: 17006326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative infectious serology testing of pre- and post-mortem blood samples from cornea donors.
    Wilkemeyer I; Pruss A; Kalus U; Schroeter J
    Cell Tissue Bank; 2012 Aug; 13(3):447-52. PubMed ID: 22802139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
    Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
    Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid testing and tissue safety: an eye bank's five-year review of HIV and hepatitis testing for donor corneas.
    Heck E; Brown A; Cavanagh HD
    Cornea; 2013 Apr; 32(4):503-5. PubMed ID: 23023406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular biological screening of viruses important to transfusion medicine].
    Wolff C; Hörnschemeyer D; Skurtopulos M; Petersen N; Beyer J; Seidel K; Mutz A; Kleesiek K
    Beitr Infusionsther Transfusionsmed; 1994; 32():102-9. PubMed ID: 9480064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
    Roth WK; Weber M; Seifried E
    Lancet; 1999 Jan; 353(9150):359-63. PubMed ID: 9950441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.
    Aswad S; Khan NS; Comanor L; Chinchilla C; Corado L; Mone T; Mendez R; Mendez R
    J Viral Hepat; 2005 Nov; 12(6):627-34. PubMed ID: 16255764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.